Associated Papers
Machine learning algorithms for predicting colchicine resistance in familial Mediterranean fever.
Öztürk A et al.
Rheumatology (oxford, England), 2026
Familial Mediterranean Fever Presenting with Recurrent Abdominal Pain without Periodic Fever following COVID-19: A Case Report.
Ueno N et al.
Internal Medicine (tokyo, Japan), 2026
Evaluation of pediatric FMF patients with biallelic pathogenic exon 10 variants: focus on chest pain.
Tunce E et al.
European Journal of Pediatrics, 2026
Genetic, and clinical features in Italian and lebanese subjects with familial mediterranean fever (FMF).
Jaber N et al.
European Journal of Internal Medicine, 2026
Long-Term outcomes of children diagnosed with indeterminate colitis.
Cetinoglu S et al.
Arab Journal of Gastroenterology : the Official Publication of the Pan-arab Association of Gastroenterology, 2026
Cachexia as an unusual presentation of familial Mediterranean fever: A case report.
Sira AM et al.
World Journal of Clinical Cases, 2026
The Relationship Between Gene Subtypes, Symptoms, and Cardiac Function in Patients with Familial Mediterranean Fever.
Kızılkaya B et al.
Journal of Clinical Medicine, 2026
Is the decision maker a key determinant of colchicine withdrawal success in paediatric heterozygous familial Mediterranean fever patients?
Özomay Baykal G et al.
Scandinavian Journal of Rheumatology, 2026
Impact of MEFV gene variants on clinical presentation in Familial Mediterranean Fever: A focus on Exon 2 mutations.
Kulaksiz B et al.
Reumatologia Clinica, 2026
Growth and pubertal development in children with familial Mediterranean fever under colchicine therapy.
Bayrak Demirel O et al.
European Journal of Pediatrics, 2025
Comparative genetic analysis of blood and semen samples in sperm donors from Hunan, China.
Huang C et al.
Annals of Medicine, 2025
[Use of IL-1 inhibitors in the treatment of familial Mediterranean fever in pediatric rheumatology].
Hillekamp C et al.
Zeitschrift Fur Rheumatologie, 2025
Identification of pathogenic MEFV variants in Korean patients with familial Mediterranean fever via whole-genome sequencing: a case report.
Choi SR et al.
Journal of Rheumatic Diseases, 2025
Different arthritis patterns in pediatric familial Mediterranean fever: Focus on exon 10 biallelic pathogenic genotypes.
Tunce E et al.
Joint Bone Spine, 2025
Non-canonical manifestations of FMF in homozygous M694V MEFV genotype: Insights from a large patient cohort.
Giat E et al.
Seminars in Arthritis and Rheumatism, 2025
The impact of homozygous mutations in exon 10 on musculoskeletal findings in children with familial mediterranean fever.
Ozbakir C et al.
European Journal of Pediatrics, 2025
Neurological involvement in children with familial Mediterranean fever: a systematic review.
La Bella S et al.
Pediatric Rheumatology Online Journal, 2025
Nutritional status in children with familial Mediterranean fever.
Bahçeci O et al.
Postgraduate Medicine, 2025
Predicting homozygous M694V genotype in paediatric FMF: multicentre analysis and scoring system proposal.
Tunce E et al.
Rheumatology (oxford, England), 2025
R202Q homozygosity of Mediterranean fever gene is associated with atypical clinical phenotype of familial Mediterranean fever.
Sagris D et al.
European Journal of Internal Medicine, 2025
Diagnostic yield of expanded carrier screening of a multi-ethnic population in yunnan, China.
Wang H et al.
Scientific Reports, 2025
Characteristics and outcomes of adult patients with familial Mediterranean fever: Comparison of patients with one versus two pathogenic exon 10 MEFV mutations.
Dumont A et al.
Joint Bone Spine, 2025
Pediatric Immunoglobulin A Vasculitis: Impact of Mediterranean Fever Gene Variants on Clinical Course and Inflammatory Markers.
Tunce E et al.
Turkish Archives of Pediatrics, 2025
Elderly-onset Familial Mediterranean Fever Carrying MEFV Exon 10 Variants in a Japanese Patient.
Fujita Y et al.
Internal Medicine (tokyo, Japan), 2025
Role of Mutual Information Profile Shifts in Assessing the Pathogenicity of Mutations on Protein Functions: The Case of Pyrin Variants Associated With Familial Mediterranean Fever.
Hacisuleyman A et al.
Proteins, 2025
Childhood Familial Mediterranean Fever in the United States: Spectrum of Clinical Phenotypes and MEFV Genotypes in a Cohort From Southeast Michigan.
Fathalla BM et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases, 2025
Unexpectedly high prevalence of familial Mediterranean fever in Slovakia.
Jesenak M et al.
Clinical and Experimental Medicine, 2025
Renal outcomes and survival in amyloidosis associated with familial Mediterranean fever: A longitudinal study.
Ozeri DJ et al.
Seminars in Arthritis and Rheumatism, 2025
Genetic and clinical features of familial Mediterranean fever in a cohort of patients with kidney failure.
Sheyyab A et al.
Journal of Nephrology, 2025
Familial Mediterranean Fever; Recent Advances, Future Prospectives.
Romano M et al.
Diagnostics (basel, Switzerland), 2025
A treatment algorithm for familial Mediterranean fever patients with menstruation-associated attacks.
Batu ED et al.
Rheumatology (oxford, England), 2025
In Silico Study of Pyrin and 14-3-3 Protein Modulation During FMF and PAAND.
Paronyan A et al.
Acs Omega, 2025
Increasing Importance of Genotype-Phenotype Correlations Associated with Common and Rare MEFV Gene Mutations in FMF Patients in the Last Thirty Years.
Yildirim S et al.
Journal of Clinical Medicine, 2025
Germline predisposition in multiple myeloma.
Martins Rodrigues F et al.
Iscience, 2025
The effect of gene dosage and age at the disease onset on the severity of familial Mediterranean fever.
Polat MC et al.
Postgraduate Medicine, 2025
Regional patterns of genetic variants in expanded carrier screening: a next-generation sequencing pilot study in Fujian Province, China.
Guo D et al.
Frontiers in Genetics, 2025
Exploring the Role of MEFV Gene Mutations in Pediatric Drug-Resistant Epilepsy.
Habibi A et al.
Iranian Journal of Child Neurology, 2025
Association of Inflammasome Gene Expression Levels with Pathogenesis of Familial Mediterranean Fever in Armenians.
Hayrapetyan V et al.
International Journal of Molecular Sciences, 2024
The journey of MEFV heterozygous children: with or without colchicine.
Çakan M et al.
European Journal of Pediatrics, 2024
Inflammatory biomarker analysis confirms reduced disease severity in heterozygous patients with familial Mediterranean fever.
Elhani I et al.
Rmd Open, 2024
Familial Mediterranean Fever-Associated Retinal Vasculitis: A Rare Manifestation Successfully Managed with IL-1 Pathway Inhibitors.
Anglada-Masferrer N et al.
Ocular Immunology and Inflammation, 2024
Characteristics of arthritis in patients with familial Mediterranean fever.
Yenigun S et al.
Internal Medicine Journal, 2024
Exome sequencing for assessing the risk of 453 monogenic disorders in offspring: A study of 832 Chinese couples.
Ding X et al.
Clinical and Translational Medicine, 2024
WES-based screening of 7,000 newborns: A pilot study in Russia.
Shubina J et al.
Hgg Advances, 2024
Cost-saving approach with screening of selected variants in genetic diagnosis in Turkish pediatric familial Mediterranean fever patients: a single center longitudinal study.
Sözeri B et al.
The Turkish Journal of Pediatrics, 2024